Syed Najmuddin, S. U. F. (2019). Efficacy of recombinant Newcastle disease virus, RAF-IL12 as a potential therapeutic cancer vaccine in CT26 and HT29 cancer cell line and in mouse model.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Syed Najmuddin, Syed Umar Faruq. Efficacy of Recombinant Newcastle Disease Virus, RAF-IL12 as a Potential Therapeutic Cancer Vaccine in CT26 and HT29 Cancer Cell Line and in Mouse Model. 2019.
توثيق جمعية اللغة المعاصرة MLA (الطبعة الثامنة)Syed Najmuddin, Syed Umar Faruq. Efficacy of Recombinant Newcastle Disease Virus, RAF-IL12 as a Potential Therapeutic Cancer Vaccine in CT26 and HT29 Cancer Cell Line and in Mouse Model. 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.